Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in

  News Archive

Too Many Avoidable Errors in Patient Care, Says Report
Tuesday, March 08, 2016
Researchers at Imperial College London have launched the reports in which provide evidence on the current state of patient safety and how it could be improved the future.

SomaLogic Raises Up to $60.5 Million From Visium Healthcare Partners
Tuesday, March 08, 2016
Company has announced that it has received up to $60.5 million through a combination of debt and equity financing from Visium to support strategic growth initiatives.

Tri-Con 2016 Marks New Era of Genomic Medicine
Monday, March 07, 2016
Mike Furness of Congenica says that Molecular Medicine Tri-Con 2016 comes at an exciting time for the industry.

Marijuana use Disorder is Common and often Untreated
Saturday, March 05, 2016
Researchers at NIH have found that the marijuana use disorder linked to substance use/mental disorders and disability.

Big and Small Numbers are Processed in Different Sides of the Brain
Saturday, March 05, 2016
Researchers at Imperial College London have suggested that the small numbers are processed in the right side of the brain, while large numbers are processed in the left side of the brain.

Discovery of Likely Subtypes of Rare Childhood Brain Tumor Signals Diagnostic Advance
Saturday, March 05, 2016
Researchers at St. Jude Children’s Research Hospital and German Cancer Research Center have identified that the molecular analysis is likely to improve classification and diagnosis of a rare brain tumor and advance precision medicine.

Clinatec Announces €30m Fundraising Campaign to Speed Research
Saturday, March 05, 2016
Company has announced that the projects include adapting a brain-computer interface to an exoskeleton system to provide mobility to quadriplegics and using NIR to slow Parkinson’s disease.

Rosetta Receives Approval for RosettaGX Reveal™
Friday, March 04, 2016
Company has announced conditional approval status for RosettaGX Reveal™, its novel microRNA classifier for the diagnosis of indeterminate thyroid fine needle aspirate.

NanoString Technologies and Merck Expand Collaboration
Friday, March 04, 2016
Company has announced collaboration to develop and commercialize novel diagnostic test to predict response to keytruda® (pembrolizumab) Merck's anti-PD-1 therapy.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 2179
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos